Although the clinical meaning of PD-L1 expression remains unclear in SCLC, some studies had demonstrated that the PD-L1-positive rate was relatively low, suggesting the main T-cell co-inhibition pathway may not be the PD-1/L1 axis in SCLC (39–42). This evidence concerns the gene CD274 and small cell lung carcinoma.